SABCS: Active Monitoring Noninferior to Guideline Care for Ductal Carcinoma in Situ
Two-year cumulative rate of invasive ipsilateral breast cancer 5.9 and 4.2 percent for guideline-concordant care, active monitoring
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.